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OBJECTIVES The aim of this study was to use real-time three-dimensional echocardiography (3DE) to
investigate the quantitative relation between minimal left ventricular (LV) outflow tract area
(ALVOT) and maximal LV outflow tract (LVOT) velocity in patients with hypertrophic
obstructive cardiomyopathy (HCM).
BACKGROUND In patients with HCM, LVOT velocity should change inversely with minimal ALVOT unless
LVOT obstruction reduces the pumping capacity of the ventricle.
METHODS A total of 25 patients with HCM with systolic anterior motion (SAM) of the mitral valve
leaflets underwent real-time 3DE. The smallest ALVOT during systole was measured using
anatomically oriented two-dimensional “C-planes” within the pyramidal 3DE volume.
Maximal velocity across LVOT was evaluated by two-dimensional Doppler echocardiography
(2DE). For comparison with 3DE ALVOT, the SAM-septal distance was determined by
2DE.
RESULTS Real-time 3DE provided unique information about the dynamic SAM-septal relation during
systole, with ALVOT ranging from 0.6 to 5.2 cm
2 (mean: 2.2  1.4 cm2). Maximal velocity
(v) correlated inversely with ALVOT (v  496 ALVOT
0.80, r  0.95, p  0.001), but the
exponent (0.80) was significantly different from 1.0 (95% confidence interval: 0.67 to
0.92), indicating a significant impact of small ALVOT on the peak LVOT flow rate. By
comparison, the best correlation between velocity and 2DE SAM-septal distance was
significantly (p  0.01) poorer at 0.83, indicating the superiority of 3DE for assessing
ALVOT.
CONCLUSIONS Three-dimensional echocardiography-measured ALVOT provides an assessment of HCM
geometry that is superior to 2DE methods. These data indicate that the peak LVOT flow rate
appears to be significantly decreased by reduced ALVOT. Real-time 3DE is a potentially
valuable clinical tool for assessing patients with HCM. (J Am Coll Cardiol 2002;39:
308–14) © 2002 by the American College of Cardiology
Hypertrophic cardiomyopathy (HCM) is defined as the
presence of a hypertrophied, nondilated left ventricle (LV)
with an absence of other diseases capable of producing
significant hypertrophy. Hypertrophy of the interventricular
septum (IVS), a narrowed LV outflow tract (LVOT) and,
frequently, systolic anterior motion (SAM) of the mitral
valve resulting in LVOT obstruction are important clinical
features of HCM. Echocardiography is the noninvasive
method of choice for the evaluation of morphologic and
functional abnormalities (1–3). However, two-dimensional
Doppler echocardiography (2DE) provides only limited
quantitative parameters such as the degree of local interven-
tricular septal thickness and distribution of hypertrophy. It
may, therefore, fail to fully characterize the LVOT in HCM
(4–9). Three-dimensional echocardiography (3DE) has the
ability to provide unique information on the spatial geom-
etry of a given structure (10). Recently developed real-time
3DE has overcome the limitations of technically cumber-
some reconstructed 3DE (11–14), but its application in
HCM has not yet been demonstrated.
When steady flow passes through an obstruction, velocity
should be related to obstruction area in a precise inverse
relation. However, if the obstruction is enough to actually
reduce flow rate, then the relation will be “flatter” than
inverse, with velocity rising less than expected with falling
LVOT area. Controversy exists over the functional signifi-
cance of LVOT obstruction in HCM with some work
suggesting that the pressure gradient (PG) implied by high
velocity in the LVOT does not significantly impact LV
ejection (15,16), insisting that the most important “obstruc-
tion” occurs during diastolic filling (17). Others note a fall in
midcavitary LV velocity at the time of maximal LVOT
velocity, implying functionally significant obstruction (18).
The purpose of this study was, therefore, to establish the
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superiority of real-time 3DE over standard 2DE methods in
assessing LVOT geometry and then use this technique to
test the hypothesis that LVOT obstruction in HCM pro-
duces a significant reduction in the peak LVOT flow rate.
METHODS
Forty consecutive patients with HCM underwent both
real-time 3DE and 2DE at the Cleveland Clinic Founda-
tion in 1998. Twenty-five patients with optimal image
quality of 3DE (16 men, average age: 53  18 years) were
enrolled. Routine 2DE was performed for each patient
followed within 10 min by real-time 3DE with unchanged
hemodynamic conditions.
Real-time 3DE. Images were obtained transthoracically by
a three-dimensional echocardiographic system with a
2.5 MHz phased array transducer (Volumetrics Medical
Imaging Inc., Durham, North Carolina) (11–14). Two
3DE datasets from parasternal and apical windows (14)
were acquired with the patients in a left lateral decubitus
position.
Conventional 2DE and Doppler echocardiography.
RATIO OF SEPTUM TO POSTERIOR WALL THICKNESS (PWT).
The thickness of basal IVS and posterior wall was measured
from a standard M-mode echocardiogram (19), and the
ratio was calculated.
DEGREE OF SAM. After we surveyed the closest approach of
the anterior mitral leaflet to the septum, the minimal
mitral-septal distance was measured with 2DE, as a dis-
placement of the anterior mitral leaflet toward the septum in
systole. It was graded as mild, moderate or severe (20).
MAXIMAL VELOCITY AND PEAK PG. Continuous-wave
Doppler was used to measure maximal velocity (v) across
LVOT. Then PG was estimated by using the simplified
Bernoulli equation, p  4v2 (21).
MITRAL REGURGITATION. Mitral regurgitant (MR) volume
and MR orifice area were determined by the flow conver-
gence method (22).
Analysis of real-time 3DE images. After the real-time
3DE image acquisition, parasternal images were displayed
on the screen as seen in Figure 1. To show the LVOT in
three dimensions during SAM, the echocardiography
Abbreviations and Acronyms
ALVOT  area of left ventricular outflow tract
CI  confidence interval
HCM  hypertrophic cardiomyopathy
IVS  interventricular septum
LV  left ventricle or left ventricular
LVOT  left ventricular outflow tract
MR  mitral regurgitant
PG  pressure gradient
PWT  posterior wall thickness
Qmax  peak cardiac outflow
SAM  systolic anterior motion of mitral valve
leaflets
v  peak velocity
2DE  two-dimensional echocardiography
3DE  three-dimensional echocardiography
Figure 1. Real-time three-dimensional echocardiographic image obtained from parasternal window at midsystolic phase in a patient with hypertrophic
cardiomyopathy. The right top and bottom images are parasternal long-axis and short-axis view images from B-scans, respectively. The left two images
are the two parallel C-plane images (C1 and C2) obtained from cutting planes, which are shown on the right in green lines perpendicular to the long axis
of the left ventricular outflow tract (LVOT). The area of the LVOT was traced shown in red in the three short-axis planes. The smallest area was counted
as the area of LVOT in this particular systolic phase. Ao  aorta; LA  left atrium; LV  left ventricle.
309JACC Vol. 39, No. 2, 2002 Qin et al.
January 16, 2002:308–14 Real-Time 3DE in HCM
B-scan sector tilt was moved carefully to display the SAM
clearly on the two orthogonal planes (i.e., parasternal
long-axis view [right top] and parasternal short axis view
[right bottom]). The cutting planes (C-scans) were tilted
and crossed the SAM perpendicular to the long axis of
LVOT (two green lines in right top). These short axis views
of the LVOT at different levels were shown in two C-scans
(left panel). Then, the areas of LVOT in three short axis
views were traced (shown in red lines), and the smallest area
was counted as ALVOT for the particular systolic phase. The
3DE images were displayed frame by frame during systole
to search for the narrowest LVOT. All measurements were
performed by an experienced investigator in real-time 3DE
analysis and without knowledge of the conventional 2DE
Doppler measurements.
Inter- and intraobserver variabilities. In order to assess
the effect of observational variability on the real-time 3DE
measurement for area of LVOT (ALVOT), the real-time
3DE images of three patients were examined. The areas of
LVOT on each frame during systole were measured by two
independent observers and by the same observer on a
different day.
Statistical analysis. All data are presented as the mean
value  SD. To assess the hypothesis that three-
dimensional methods provide a better assessment of LVOT
geometry than two-dimensional methods, linear regression
was used to examine the relation between PG and: 1)
ALVOT (3DE parameter); 2) mitral-septal distance; and 3)
IVS/PWT. Analysis of variance was used to compare the
differences in PG and in MR volume between the mild,
moderate and severe SAM groups. Unpaired t testing was
used to compare PG between patients with ALVOT 2 cm
2
and those with ALVOT2 cm
2 by real-time 3DE. A p value
0.05 was considered significant.
To test the hypothesis that SAM produces functional
LVOT obstruction, we noted that if peak cardiac outflow
(Qmax) were independent of the degree of obstruction, then
there should be a precisely inverse relation between peak
velocity (y) and ALVOT (x), y  Qmax/x. Similarly, because
of the squared relation between maximal velocity and PG,
we anticipated an approximate inverse squared relation
between peak gradient and ALVOT. To test this hypothesis,
we fit the observed data into a general power law formula of
the form y  x using Levinberg-Marquardt nonlinear
parameter estimation. If high degrees of obstruction do
reduce peak flow rate,  should be slightly 1 when y
represents velocity and 2 when y represents PG. For
comparison purposes, we let x represent SAM distance and
repeated the nonlinear regression with y  (x  ). An
additional parameter, , is necessary, as a SAM distance of
zero cannot be entered into a general power law fit.
RESULTS
2DE findings. SAM. Of the 25 patients, there was mild
SAM in nine patients, moderate SAM in nine patients and
severe SAM in seven patients. The minimal mitral-septal
distance was 13.1 1.8 mm, 4.6 2.3 mm and 0 0 mm,
respectively, p  0.001.
RATIO OF SEPTUM TO PWT. The thickness of IVS measured
by M-mode was 22  5 mm (range: 12 to 34 mm); the
thickness of posterior wall was 15  5 mm (range: 8 to
29 mm) and the ratio of septum to PWT was 1.5  0.3
(range: 0.9 to 2.5) in the 25 patients. There were three
patients whose ratio was 1.3, but their PGs were signifi-
cantly higher after amyl nitrite inhalation with SAM dem-
onstrated. There were no significant differences among the
three SAM grade groups for septal thickness, PWT and the
ratio of IVS to PWT (Table 1).
MAXIMAL VELOCITY AND PG. The maximal velocity across
the LVOT measured by continuous wave Doppler averaged
3.3  1.7 m/s (range: 0.5 to 7.4 m/s), while PG averaged
56  50 mm Hg (range: 4 to 221 mm Hg). Significant
differences were seen for these indexes across the three
grades of SAM (Table 1).
Mitral regurgitation. Mitral regurgitant volume and MR
orifice area in the severe SAM group were significantly
larger than those in mild SAM group (Table 1).
3DE findings. The real-time 3DE system provided unique
three-dimensional information about the SAM and its
dynamic relation to the septum during systole allowing us to
determine the smallest ALVOT in three-dimensional space
(Fig. 1).
The smallest ALVOT during systole, determined by real-
time 3DE, averaged 2.2  1.4 cm2 (range: 0.6 to 5.2 cm2).
Sixteen of 25 patients had an ALVOT 2 cm
2. The PGs in
patients with ALVOT 2 cm
2 were significantly higher than
those in patients with ALVOT 2 cm
2 (80  48 mm Hg vs.
13  5 mm Hg, p  0.01). All patients with ALVOT
2 cm2 had PG 50 mm Hg, while all patients with
ALVOT 2 cm
2 had PG 50 mm Hg (Fig. 2).
The temporal changes of ALVOT were also analyzed in
seven of 25 patients with HCM. The average frames in
systole were 7  1 frames/beat. The ALVOT significantly
decreased from the beginning of systole to midsystole







IVS (mm) 21  7 22  4 22  2
PWT (mm) 16  6 15  6 14  1
IVS/PWT 1.5  0.4 1.6  0.4 1.7  0.2
PG (mm Hg) 35  38 48  33 102  57*
Vmax (m/s) 2.6  1.5 2.9  1.5 4.9  1.3*
ALVOT (cm
2) 2.5  1.3 2.3  1.3 1.2  0.6
MRV (ml) 19  13 37  14 59  15†
MROA (cm2) 0.08  0.03 0.15  0.05 0.26  0.08†
*Comparison with mild and moderate SAM groups, p 0.05; †comparison with mild
SAM group, p  0.05.
ALVOT  area of left ventricular outflow tract; IVS  interventricular septum
thickness; MVR  mitral regurgitant volume; MROA  mitral regurgitant orifice
area; PG  pressure gradient; PWT  posterior wall thickness; SAM  systolic
anterior motion of mitral valve leaflets; Vmax  maximal velocity through left
ventricular outflow tract.
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(2.5  0.8 cm2 vs. 1.3  0.3 cm2, p  0.01) and remained
similar at end-systole (1.1 0.4 cm2 vs. 1.3 0.3 cm2, p
0.05).
Relations between maximal velocity, PG, ALVOT and
SAM distance. For both maximal velocity and PG, simple
linear correlation was stronger with ALVOT obtained from
real-time 3DE (r  0.87 and 0.75, respectively) than it
was with the SAM distance derived from M-mode (r 
0.79 and 0.69, respectively). Even more illustrative is
the nonlinear regression analysis. As shown in Table 2,
strong correlations were seen in the power law relationship
between ALVOT and maximal velocity (r  0.95, Fig.
3),with an exponent of 0.80 (95% confidence interval
[CI]:0.67 to0.92), close to the theoretical prediction of
1.0, but it indicates a significant degree of flow reduction
with increasing obstruction. In contrast, the SAM-septal
distance was much less predictive of maximal velocity with
r  0.83 (despite the additional degree of freedom  in
the nonlinear equation) and an exponent of 2.36, well
away from the predicted 1.0 (95% CI: 12.81 to 8.09).
Similar findings were observed when peak pressure drop was
used as the dependent variable. The ALVOT predicted
pressure drop with r  0.96 and an exponent of 1.46
(95% CI: 1.67 to 1.24), significantly better than the r 
0.77 and   3.17 (95% CI: 25.8 to 19.4) observed
for SAM-septal distance.
The ALVOT by 3DE also correlated moderately well with
MR volume (r  0.73) and MR orifice area (r  0.58)
when linear correlation analysis was used. However, ALVOT
and PG did not relate to the ratio of septum to PWT.
Observer variabilities. For a total of 19 ALVOT measure-
ments, there was good agreement between the two inde-
pendent observers for interobserver variability (1.4 
0.8 cm2 vs. 1.4  0.7 cm2, r  0.95, p  0.0001, mean
difference  0.01  0.23 cm2) and between the different
day’s measurements for the intraobserver variability (1.4 
0.8 cm2 vs. 1.4  0.7 cm2, r  0.97, p  0.0001, mean
difference  0.07  0.19 cm2).
DISCUSSION
Previous echocardiographic studies of HCM. Initial
M-mode echocardiographic studies verified that SAM of
the anterior mitral valve was a typical sign of HCM (23).
Conventional 2DE assists in distinguishing several patterns
of LV hypertrophy, observing dynamic mitral valve motion
and defining the relation between SAM and IVS. Contin-
uous wave Doppler echocardiography provides noninvasive
blood velocity and PG measurements across the LVOT,
which has guided the choice of treatments such as medicine,
surgery or, more recently, alcohol ablation. However, the
accurate quantitative assessment of such a key parameter as
the smallest ALVOT during systole, the ultimate determi-
nant of LVOT obstruction, has been impossible with the
methods mentioned above.
In previous work, 3DE reconstructions of the LVOT
demonstrated the significantly smaller ALVOT in patients
Figure 2. Pressure gradient (PG) across left ventricular outflow tract
(LVOT) in the area of LVOT 2 cm2 and 2 cm2 groups. 3DE 
three-dimensional echocardiography.
Table 2. Nonlinear Regression Parameters for y   (x  )
Independent Dependent    r
SAM Vmax 687,953 2.36 21.2 0.83
PG 490,046 3.17 14.2 0.77
ALVOT Vmax 496 0.80 0.95
PG 99 1.46 0.96
Abbreviations as in Table 1.
Figure 3. The power correlations between maximal velocity across left
ventricular outflow tract (LVOT) and area of LVOT (A) and systolic
anterior motion of mitral valve leaflets (SAM)-septum distance (B). Vmax 
maximal velocity through LVOT.
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with HCM as compared with normal control subjects (24),
while transesophageal acquisition of 3DE data sets provided
even better image quality (25). Although both of these 3DE
reconstruction methods were able to show the ALVOT
dynamically, they required electrocardiogram and respira-
tory gating, special instruments for holding the probe and
long acquisition times. Because of their sensitivity to patient
movement, 3DE reconstruction applications are quite lim-
ited in the clinical setting.
Quantitative analysis of real-time 3DE. To our knowl-
edge, this is the first study to demonstrate the relation
between the smallest ALVOT and LVOT velocity and PG
using real-time 3DE. In this study, LVOT and SAM
structure were displayed clearly in three-dimensional space.
Measurement of ALVOT is uniquely possible with real-time
3DE, as complete spatial information is available in a single
heartbeat without the vagaries of reconstructing over mul-
tiple beats. The minimal ALVOT during systole observed in
this study is similar to that previously reported with trans-
thoracic 3DE reconstruction (24). That report also showed
that the smallest ALVOT in patients with HCM (2.3 
1.0 cm2) was significantly smaller than that in normal
control patients (5.0  0.9 cm2) (24), with a highly
eccentric and asymmetric shape of the LVOT and a
tendency to decrease with increasing degrees of SAM.
However, even in the severe SAM group, there was not
complete LVOT obstruction with a small ALVOT (1.2 
0.5 cm2), although the PG was high (102  57 mm Hg),
which was similar to our observations.
In this study, only a moderate linear correlation between
the smallest ALVOT and the PG was found (r0.75), but
this increased dramatically when the theoretically sound
power function was used (r  0.96). For a fixed flow
(Qmax) situation, the maximal velocity across the LVOT (v)
should be the precise inverse of ALVOT: vQmaxALVOT
1.
In this case, the actual magnitude of the exponent was
somewhat lower at 0.8, indicating that velocity did not rise
quite as fast with decreasing ALVOT, as would be expected
if flow rate were a constant (Fig. 3). The most probable
explanation for this is that peak flow is reduced at increasing
levels of obstruction, an issue that has been the subject of
some controversy (15,16,26). In contrast, the power law
relation between SAM-septal distance and maximal velocity
and gradients could not even be calculated without an
additional parameter () to offset the zero SAM distance
value commonly observed. Even with this additional degree
of freedom to the model, the overall correlation was signif-
icantly worse than with ALVOT. Thus, the observed expo-
nents did not make physiological sense. Taken at face value,
they would imply increasing flow with increasing degrees of
obstruction, a physically implausible situation.
Using 50 mm Hg as a dividing point, there is complete
separation of the patients into two groups with ALVOT
2 cm2 and ALVOT 2 cm
2 (Fig. 2). If the ALVOT is 2
cm2, the PG can be expected to be higher than 50 mm Hg
in patients with HCM, and more aggressive clinical inter-
ventions such as ablation (27,28) or myectomy (29) could be
considered. The decrease of the PG has been used as a
means of assessing response to therapy in patients with
HCM. But the PG varies considerably from day to day even
in stable patients with HCM (the variation was  32 mm
Hg for rest PG and  50 mm Hg for provoked PG) (30).
A single measurement of the PG was not adequate to define
the severity of dynamic LVOT obstruction in HCM (30).
Although serial examinations were not performed in these
patients, we would expect ALVOT to show similar variability
with changing loading conditions, thus requiring examina-
tion at multiple points in time. However, it may be that the
analysis of the geometric relation between the anterior
mitral leaflets and the IVS may provide some useful infor-
mation guiding therapy and allowing refinements of surgical
and ablation techniques.
Functional obstruction in HCM. From the earliest cath
lab studies (31), a dynamic pressure drop across the LVOT
has been considered characteristic of HCM, especially after
provocative maneuvers (32). This “mantra” has been called
into question by several investigators including Murgo et al.
(15) and Criley (16), who have rightly pointed out that, in
patients with HCM, there is hyperdynamic ventricular
emptying despite outflow tract gradients and little relation
between the magnitude of these gradients and prognosis in
HCM. In contrast, Sherrid et al. (33) have suggested a
spiraling positive feedback loop in which obstruction is
amplified by pressure against the anterior mitral leaflet. This
produces further obstruction and results in a midsystolic fall
in velocities (and, therefore, flow) within the LV cavity at
the time of maximal LVOT velocity (18). Our data differ in
that they are derived from a cross-section of patients studied
at a given point in time, but they are consistent with the
observation that patients with the smallest ALVOT have
maximal velocities that fall short of the inverse relation
anticipated if LV outflows were unaffected by the obstruc-
tion. The impact is not large, as our observed exponent
0.8 came close to the 1 expected for an inverse relation,
but the impact appears to be real. Adding further to the
confusion is the observation that pressure recovery may
occur distal to the obstruction (34). This may explain some
Doppler-catheter discrepancies. In addition, LVOT flow is
different from patient to patient and changes during systole
even in the same patient. Nevertheless, the data of Sherrid
et al. (18) along with our own suggests that the LV does
indeed “feel” the obstruction, while mitral regurgitation is a
confounding variable in this setting.
Study limitations. The greatest limitations for quantitative
analysis of real-time 3DE are relatively low image quality
and resolution, and only 25 of 40 consecutive patients had
optimal images for quantitative analysis in this study. This
may overstate the problem, however, as we sought to enroll
only patients with the highest quality images to establish the
relation between ALVOT and maximal velocity and PG;
many other patients had reasonable image quality that could
have been used for clinical assessment purposes. Temporal
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resolution is low, 22 frames per second at the scanning
depth of 12 cm in the current 3DE system as compared with
M-mode (1 kHz) and 2DE systems (more than 30 Hz). It
might affect the accuracy of ALVOT measurements. Another
limitation of this study is the lack of an independent
reference method for the analysis of the smallest ALVOT,
owing to the fact that no other method has been shown to
accurately delineate the minimal ALVOT and its cardiac
cyclical changes. Finally, it was impossible to obtain con-
tinuous wave Doppler recording simultaneous with 3DE
images. Although the patients were all in sinus rhythm and
in a stable hemodynamic state, we cannot exclude some
minor degree of changes in LVOT obstruction between the
times of the two examinations.
CONCLUSIONS
Real-time 3DE enables morphologic description of the
LVOT and quantitative evaluation of the minimal area of
LVOT in patients with HCM. The smallest area of LVOT
measured by real-time 3DE revealed an excellent correlation
with maximal velocity and PGs across LVOT, consistent
with the physiological expectations, suggesting the potential
importance of real-time 3DE for evaluating patients with
HCM.
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